About Children's Cancer and Blood Disorders Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Children's Cancer and Blood Disorders Center
During the past decade, Children's Cancer and Blood Disorders Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
2004-08-01
2009-05-01
Completed
100
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
2008-09-03
2016-02-25
Completed
723
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2010-01-01
2015-12-01
Completed
1,069
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2009-09-01
2016-01-01
Completed
347
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
2009-09-30
2017-11-02
Completed
1,199
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
2011-01-13
2016-11-30
Completed
343
Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer
2012-11-23
2019-02-12
Completed
156
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
2013-02-22
2023-08-26
Active, not recruiting
666
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Children's Cancer and Blood Disorders Center
According to Clinical.Site data, the most researched conditions in "Children's Cancer and Blood Disorders Center" are
"Cancer" (2 trials), "Breakthrough Pain" (1 trials), "Pain" (1 trials), "Severe Burns" (1 trials) and "Sickle Cell Anemia" (1 trials). Many other conditions were trialed in "Children's Cancer and Blood Disorders Center" in a lesser frequency.
Clinical Trials Intervention Types at Children's Cancer and Blood Disorders Center
Most popular intervention types in "Children's Cancer and Blood Disorders Center" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "ACTIQ (Oral Transmucosal Fentanyl Citrate [OTFC])" (1 trials) and "ACTIQ®" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Children's Cancer and Blood Disorders Center
The vast majority of trials in "Children's Cancer and Blood Disorders Center" are
2 trials for "All" genders.
Clinical Trials Status at Children's Cancer and Blood Disorders Center
Currently, there are NaN active trials in "Children's Cancer and Blood Disorders Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Children's Cancer and Blood Disorders Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Children's Cancer and Blood Disorders Center, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".